These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38105167)

  • 1. p16 and p53 can Serve as Prognostic Markers for Head and Neck Squamous Cell Carcinoma.
    Wang Y; Wang F; Wang S; Zhang L; Fu H; Sun L; Wang W; Liu C; Ren W; Gao L; Xing G; Ma X
    Int Dent J; 2024 Jun; 74(3):543-552. PubMed ID: 38105167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16, p53 and EGFR expression in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters.
    Gupta S; Pandey P; Verma S; Verma A
    J Cancer Res Ther; 2024 Apr; 20(3):881-887. PubMed ID: 39023595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
    Owusu-Afriyie O; Owiredu WKBA; Owusu-Danquah K; Komarck C; Foltin SK; Larsen-Reindorf R; Acheampong E; Quayson SE; Prince MEP; McHugh JB; Donkor P; Merajver SD; Brenner JC
    PLoS One; 2018; 13(8):e0202790. PubMed ID: 30138436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of the expression of p53 and p16INK4A with the clinical and morphological characteristicsof patients with head and neck squamous cell cancer].
    Stukan AI; Chukhray OY; Porkhanov VA; Bodnya VN
    Arkh Patol; 2019; 81(3):12-18. PubMed ID: 31317926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy.
    Higuchi E; Oridate N; Homma A; Suzuki F; Atago Y; Nagahashi T; Furuta Y; Fukuda S
    Head Neck; 2007 Oct; 29(10):940-7. PubMed ID: 17563903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
    Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma.
    Richtig G; Aigelsreiter AM; Asslaber M; Weiland T; Pichler M; Eberhard K; Sygulla S; Schauer S; Hoefler G; Aigelsreiter A
    Histopathology; 2019 Jul; 75(1):118-127. PubMed ID: 30861166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.
    Yildirim M; Müller von der Grün J; Winkelmann R; Fokas E; Rödel F; Ackermann H; Rödel C; Balermpas P
    Strahlenther Onkol; 2017 Apr; 193(4):305-314. PubMed ID: 28144684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
    Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C
    Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report.
    Camacho-Urkaray E; Santos-Juanes J; Gutiérrez-Corres FB; García B; Quirós LM; Guerra-Merino I; Aguirre JJ; Fernández-Vega I
    Cell Oncol (Dordr); 2018 Apr; 41(2):213-221. PubMed ID: 29218546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
    Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
    Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.
    Lee K; Jung ES; Choi YJ; Lee KY; Lee A
    J Korean Med Sci; 2010 Oct; 25(10):1449-55. PubMed ID: 20890425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
    Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S
    Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
    Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
    Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.